mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.2 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |